The granting of a new patent to HeartBeam for a product that detects heart attacks and complex cardiac arrhythmias could potentially increase the company's market share and revenue. This is because the patent gives HeartBeam exclusive rights to produce and sell the product, potentially leading to increased sales and revenue. This could in turn drive up the price of the company's stock, BEAT.